Blue Cross And Blue Shield Face Major Lawsuits Over Operations
The antitrust lawsuits allege that the 37 independently owned companies are functioning as an illegal cartel. Also in the news, the Japanese company that manufactures the endoscopes linked to a superbug outbreak is getting ready to settle an investigation into its product marketing.
The Wall Street Journal:
Antitrust Lawsuits Target Blue Cross And Blue Shield
Blue Cross and Blue Shield health insurers cover about a third of Americans, through a national network that dates back decades. Now, antitrust lawsuits advancing in a federal court in Alabama allege that the 37 independently owned companies are functioning as an illegal cartel. A federal judicial panel has consolidated the claims against the insurers into two lawsuits that represent plaintiffs from around the country. One is on behalf of health-care providers and the other is for individual and small-employer customers. (Wilde Mathews, 5/27)
Los Angeles Times:
Scope Maker Olympus Expects To Settle U.S. Claims Over Marketing
The manufacturer of endoscopes at the center of a string of deadly superbug outbreaks has set aside nearly $450 million for an expected settlement of a U.S. investigation into its marketing of medical products.
Olympus Corp. of Japan did not disclose the details of what federal officials have been investigating other than saying the focus is on possible violations of laws that ban companies from paying kickbacks to doctors and other potential customers. (Petersen, 5/27)
